Clinical neuroscientist Joe Schacht offered an overview of the research on weight-loss drugs for alcoholism, other potential ...

Though more research is needed to understand who might benefit from GLP-1 agonists for addiction, early studies suggest that the approach holds promise.

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

New research suggests semaglutide, marketed as Ozempic for diabetes and Wegovy for obesity, could help people reduce their alcohol consumption.

After serving several tours, including Afghanistan, Stephen Kelly came home in 2012 with possible traumatic brain injury (TBI) from an explosive bomb accident. Soon after his return, his wife, ...

HB 417 would impose a 6% tax of alcohol sales. It would be paid for by the consumer at the point of sale.

All they left was dread … darkness under the bridge, where there were drugs and everything,” Alejandro Rivera said. “I took ...

Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...

A new clinical trial showed promising results in curbing alcohol cravings in individuals with moderate alcohol-use disorder.

Source: In this digital age, a lot of services are shifting from conventional physical offerings to remote offerings. The ...

Australians will wait an average of 12 years before getting treatment for mental health or substance use disorders, according ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.